<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02511769</url>
  </required_header>
  <id_info>
    <org_study_id>13-032</org_study_id>
    <nct_id>NCT02511769</nct_id>
  </id_info>
  <brief_title>Web-MAP Intervention for Youth With Sickle Cell Disease</brief_title>
  <acronym>Web-MAP</acronym>
  <official_title>WEB MAP Intervention for Youth With Sickle Cell Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Connecticut Children's Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seattle Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Connecticut Children's Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study will determine whether the efficacy of WebMAP cognitive behavioral therapy
      (CBT) treatment study generalizes to pediatric sickle cell disease (SCD), and explore whether
      the intervention is feasible and acceptable to this population. Feasibility of
      multi-institutional recruitment from sickle cell centers will also be determined. The
      short-term goal is to produce preliminary data to apply for an R01 proposal to carry out a
      multi-institutional randomized controlled trial (RCT) of internet-delivered behavioral
      intervention in a large population of youth with SCD. The long-term goal of this research is
      to develop effective, easily accessible, behavioral pain interventions for youth with SCD to
      reduce the long-term impact of pain on function, quality of life, and health service use in
      this population.

      The design of this study is an experimental 2 (group) x 3 (time of measurement) randomized
      controlled trial design to test the acceptability and efficacy of the Web-MAP intervention in
      reducing pain and functional impairment in youth with sickle cell disease. (Figure 1)
      Subjects will be randomized to either the behavioral intervention or the online patient
      education control group. The treatment protocol will be implemented over 8 weeks in
      Internet-based treatment modules. The primary study outcome is pain and functional impairment
      measured at baseline, immediately post-treatment, and at 3-month follow-up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed study will determine whether the efficacy of WebMAP generalizes to pediatric
      SCD, and explore whether the intervention is feasible and acceptable to this population.
      Feasibility of multi-institutional recruitment from sickle cell centers will also be
      determined. The short-term goal is to produce preliminary data to apply for an R01 proposal
      to carry out a multi-institutional randomized controlled trial (RCT) of internet-delivered
      behavioral intervention in a large population of youth with SCD. The long-term goal of this
      research is to develop effective, easily accessible, behavioral pain interventions for youth
      with SCD to reduce the long-term impact of pain on function, quality of life, and health
      service use in this population.

      The design of this study is an experimental 2 (group) x 3 (time of measurement) randomized
      controlled trial design to test the acceptability and efficacy of the Web-MAP intervention in
      reducing pain and functional impairment in youth with sickle cell disease. (Figure 1)
      Subjects will be randomized to either the behavioral intervention or the online patient
      education control group. The treatment protocol will be implemented over 8 weeks in
      Internet-based treatment modules. The primary study outcome is pain and functional impairment
      measured at baseline, immediately post-treatment, and at 3-month follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">August 18, 2016</completion_date>
  <primary_completion_date type="Actual">August 18, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy in pain reduction</measure>
    <time_frame>6 months</time_frame>
    <description>We will compare pain intensity (pain scores), pain burden (Sickle Cell Pain Burden Interview), activity limitations (Child Activity Limitations Interview), quality of life (PedsQL), and health service use, and their corresponding changes from baseline to T2 (immediately after finishing the treatment arm) and T3 (6 months after enrollment in study). We will used a paired sample t-test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy of reducing depressive symptoms</measure>
    <time_frame>6 months</time_frame>
    <description>We will compare changes changes in depressive symptoms using the Centers for Epidemiological Study Depression scale from baseline to T2 (immediately after finishing the treatment arm) and T3 (6 months after enrollment in study). We will used a paired sample t-test.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Feasibility of WEB-MAP program</measure>
    <time_frame>6 months</time_frame>
    <description>We will conduct interviews with participants of the study using a script to start a dialogue on how user friendly their interface is, perceived difficulties or barriers, improvements to make, and general overall feedback to modify the program.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Sickle Cell Disease</condition>
  <arm_group>
    <arm_group_label>WEB-MAP CBT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Web-MAP Group. Participants will have access to the full version of the web program. They will be asked to log in to the website using their own personal computer at home, work, school, or a public library. Participants in the Web-MAP group will have access to treatment modules and daily diaries on the web site. The online treatment will take between 8 and 9 weeks for participants to complete. Children and parents will be asked to log onto the web site, read through the treatment modules, and complete practice assignments to learn new skills (e.g., relaxation). Adolescents and parents will be asked to complete a total of 8 modules each.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>WEB-MAP Educational Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>OPEC (Online Patient Education Control) Group: The purpose of the patient education control group is to control for time, attention, and computer usage. This group will serve as an attention control condition. Children will continue with the standard medical care that has been prescribed for their pain problem. Children and parents will be provided with access to a revised version of the Web-MAP study website, which will have two functional components: 1) information from publicly available educational websites about pediatric chronic pain management, 2) diary and assessments. This version of the website differs from the one accessed by the treatment condition in that it does not provide access to behavioral and cognitive skills training via treatment modules for children and parents.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>WEB-MAP Educational Control Group</intervention_name>
    <description>OPEC (Online Patient Education Control) Group: The purpose of the patient education control group is to control for time, attention, and computer usage. This group will serve as an attention control condition. Children will continue with the standard medical care that has been prescribed for their pain problem. Children and parents will be provided with access to a revised version of the Web-MAP study website, which will have two functional components: 1) information from publicly available educational websites about pediatric chronic pain management, 2) diary and assessments. This version of the website differs from the one accessed by the treatment condition in that it does not provide access to behavioral and cognitive skills training via treatment modules for children and parents.</description>
    <arm_group_label>WEB-MAP Educational Control Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>WEB-MAP CBT</intervention_name>
    <description>Web-MAP Group: Participants will have access to the full version of the web program. They will be asked to log in to the website using their own personal computer at home, work, school, or a public library. Participants in the Web-MAP group will have access to treatment modules and daily diaries on the web site. The online treatment will take between 8 and 9 weeks for participants to complete. Children and parents will be asked to log onto the web site, read through the treatment modules, and complete practice assignments to learn new skills (e.g., relaxation). Adolescents and parents will be asked to complete a total of 8 modules each.</description>
    <arm_group_label>WEB-MAP CBT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Documented sickle cell disease (verified by physician at SCD center if referred
             participant is a self referral)

          -  11-18 years old

          -  Parental/patient consent and patient assent

          -  Internet and computer or smartphone access

          -  Score of &gt;3 on the SCPBI-Y

        Exclusion Criteria:

          -  Primary language spoken other than English

          -  11&lt;Ageâ‰¤19

          -  Serious comorbid chronic condition (e.g., diabetes, arthritis, cancer)

          -  More than 4 sessions of outpatient behavioral therapy for pain management in the 6
             months prior to the time of screening
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William T Zempsky, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Connecticut Children's Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CCMC</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2014</study_first_submitted>
  <study_first_submitted_qc>July 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2015</study_first_posted>
  <last_update_submitted>January 30, 2017</last_update_submitted>
  <last_update_submitted_qc>January 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Connecticut Children's Medical Center</investigator_affiliation>
    <investigator_full_name>William Zempsky, MD</investigator_full_name>
    <investigator_title>Head, Division of Pain and Palliative Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia, Sickle Cell</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

